Research progress and prospect of tumor nanovaccine combination therapy strategy DOI
Yanyan Yin, Jun Guo, Shuo Zhang

et al.

Chinese Chemical Letters, Journal Year: 2024, Volume and Issue: unknown, P. 110771 - 110771

Published: Dec. 1, 2024

Language: Английский

Converging frontiers in cancer treatment: the role of nanomaterials, mesenchymal stem cells, and microbial agents—challenges and limitations DOI Creative Commons
Hamed Afkhami, Aref Yarahmadi,

Shoroq Bostani

et al.

Discover Oncology, Journal Year: 2024, Volume and Issue: 15(1)

Published: Dec. 21, 2024

Globally, people widely recognize cancer as one of the most lethal diseases due to its high mortality rates and lack effective treatment options. Ongoing research into therapies remains a critical area inquiry, holding significant social relevance. Currently used treatment, such chemotherapy, radiation, or surgery, often suffers from other problems like damaging side effects, inaccuracy, ability clear tumors. Conventional are usually imprecise ineffective develop resistance treatments recurs. Cancer patients need fresh innovative that can reduce effects while maximizing effectiveness. In recent decades several breakthroughs in these, areas medical research, have paved way for new avenues fighting including more focused alternatives. This study reviews exciting possibilities mesenchymal stem cells (MSCs), nanomaterials, microbial agents modern realm treatment. Nanoparticles (NPs) demonstrated surprisingly potential. They improve drug delivery systems (DDS) significantly, enhance imaging techniques remarkably, target selectively protecting healthy tissues. MSCs play double role tissue repair vehicle novel gene NPs loaded with therapeutic agents. Additionally, utilizing agents, particularly those involving bacteria, offer an inventive approach review investigates potential MSCs, addressing shortcomings conventional therapies. We will also discuss challenges limitations using these approaches.

Language: Английский

Citations

7

Synthetic Biology‐Based Strategy for Nanomedicine Design DOI Creative Commons
Xiangyun Zhang, Qiannan Duan, Jie Zhuang

et al.

Small Methods, Journal Year: 2025, Volume and Issue: unknown

Published: March 3, 2025

Abstract Nanomedicines have demonstrated significant potential in disease diagnosis and therapy, revolutionizing traditional drug development patterns. Recently, inspired by both natural engineering principles, synthetic biology integrates the complexity of biological systems with precision to design create novel components, devices, systems. This convergence nanomedicine has led emergence a new concept: nanomedicine. Unlike or biomimetic nanomedicines, nanomedicines are designed using gene engineering‐based strategies. In this Perspective, foundational concepts introduced its relationship to, differences from, explored. Drawing from biology, also incorporates two main approaches: top‐down bottom‐up The latest advancements application reviewed, these developments categorized according aforementioned strategies, discussion advantages challenges associated utilizing is concluded.

Language: Английский

Citations

0

Thermal-responsive ultrasound activatable in situ production of therapeutics for real-time imaging and targeted tumor therapy DOI Creative Commons

Meng Du,

Fengyi Zeng, Ting Wang

et al.

Theranostics, Journal Year: 2025, Volume and Issue: 15(9), P. 4212 - 4228

Published: March 18, 2025

Rationale: Engineered bacteria with tumor-targeting capabilities and genetic modification potential have emerged as promising vectors for targeted tumor therapy through the effective production release of therapeutic molecules. Controlled gene expression real-time monitoring protein in tumors are great significance optimizing engineered well anti-tumor effects. Methods: We constructed E. coli MG1655 cells using recombinant thermal plasmid pBV220 carrying optical imaging reporter miRFP720 Cytolysin A, which could be controlled expressed synchronously by effect produced focused ultrasound. The concentrations A after ultrasound irradiation were detected vitro vivo western blot analysis enzyme-linked immunosorbent assay (ELISA) analysis. immune cell infiltration rate inflammation factors treatment flow cytometry ELISA efficacy alone or combined anti-Programmed death 1 ligand (aPD-L1) immunotherapy evaluated on subcutaneous models orthotopic glioblastoma models. Results: Upon ultrasound-controlled activation, level molecule probe enhanced. Importantly, monitored non-invasively signal intensity miRFP720, provided guidance optimized ultrasound-mediated situ. Furthermore, not only exerted potent effects but also induced immunogenic death, enhancing efficiency aPD-L1 deep site treatment. Conclusion: In this study, a guided activatable mode was established. Utilizing ultrasound, A-miRFP720 can concurrently express mode, realized enhanced local immunotherapy.

Language: Английский

Citations

0

Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers DOI Creative Commons
Qingqing Zhang,

Xiao Song,

Junhong Liu

et al.

Oncology Reviews, Journal Year: 2025, Volume and Issue: 19

Published: April 14, 2025

The high incidence and mortality rates associated with gastrointestinal cancers represent a significant global health challenge. In recent years, CAR T cell therapy has emerged as promising immunotherapeutic approach, demonstrating favorable clinical outcomes. However, the application of traditional in faces numerous challenges, including suppressive tumor microenvironment limitations anti-tumor efficacy. engineered bacteria offers novel strategy to enhance by modulating boosting immune responses, potentially leading improved therapeutic This review synthesizes current research advancements related bacteria-assisted cancers, exploring its underlying mechanisms, applications, future developmental directions.

Language: Английский

Citations

0

Nanoparticle‐Based drug delivery strategies for targeted therapy to hypoxic solid tumors DOI

ZhouXue Wu,

Junru Chen,

Biqiong Wang

et al.

Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: unknown, P. 158081 - 158081

Published: Nov. 1, 2024

Language: Английский

Citations

3

Research progress and prospect of tumor nanovaccine combination therapy strategy DOI
Yanyan Yin, Jun Guo, Shuo Zhang

et al.

Chinese Chemical Letters, Journal Year: 2024, Volume and Issue: unknown, P. 110771 - 110771

Published: Dec. 1, 2024

Language: Английский

Citations

0